FDA grants anti-malaria drugs emergency approval to treat COVID-19
Novel coronavirus, known for attacking the respiratory system and causing an illness that is officially called COVID-19, has claimed more than 34,000 lives across the globe.
But scientists are teaming up with government officials to find and approve medical therapies that will combat the virus; ABC News reports that as of Monday, the Food and Drug Administration (FDA) has given anti-malaria drugs emergency approval to treat COVID-19.
At the moment, few details regarding the approval have been provided.
This article will be updated as the federal government provides additional information regarding developments in the treatment of COVID-19.